Articles From: National Research Corporation to Broadcast Its 2014 First Quarter Conference Call Live on the Internet to NeoStem's Subsidiary, Progenitor Cell Therapy Enters Into a Services Agreement With IRX Therapeutics, Inc.


LINCOLN, Neb., April 29, 2014 (GLOBE NEWSWIRE) -- National Research Corporation (Nasdaq:NRCIA) (Nasdaq:NRCIB) today announced that it will provide an online Web simulcast of its 2014 first quarter conference call on Wednesday, May 7, 2014.
Sign-up for National Research Corporation to Broadcast Its 2014 First Quarter Conference Call Live on the Internet investment picks
HOUSTON , May 19, 2014 /PRNewswire/ --
Sign-up for Natural Resource Partners L.P. To Present at National Association of Publicly Traded Partnerships 2014 MLP Investor Conference investment picks
LEHI, Utah, May 15, 2014 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq:NATR) , a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today announced that Gregory Probert, Nature's Sunshine Products' Chairman of the Board and Chief Executive Officer and Stephen Bunker, Executive Vice President, Chief Financial Officer and Treasurer, will participate in B.
Sign-up for Nature's Sunshine Products Announces Participation in B. Riley & Co.'s 15th Annual Investor Conference investment picks
LEHI, Utah, May 5, 2014 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq:NATR) , a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today announced that it will report first quarter 2014 financial results for the period ended March 31, 2014, on Wednesday, May 7, 2014, at 4:00 p.m. Eastern Time.
Sign-up for Nature's Sunshine Products Announces Updated First Quarter 2014 Earnings Press Release Timing investment picks
LEHI, Utah, May 2, 2014 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq:NATR) , a leading natural health and wellness company, has signed a new three-year agreement with Santorin Management Corp, Ltd., extending the two companies' longstanding partnership.
Sign-up for Nature's Sunshine Renews Longstanding Partnership With Santorin to Manage Operations in Russia, Central and Eastern Europe investment picks
SAN CARLOS, Calif., May 8, 2014 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (Nasdaq:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas, NV.
Sign-up for Natus to Present at Bank of America Merrill Lynch 2014 Health Care Conference investment picks
NEWARK, Del., May 22, 2014 (GLOBE NEWSWIRE) -- Navient (Nasdaq:NAVI) , the nation's leading loan management, servicing and asset recovery company, announced today that its Board of Directors authorized a $400 million share repurchase program for the company's outstanding common stock.
Sign-up for Navient announces $400 million share repurchase program, declares common stock dividend investment picks
2014/5/5
NEWARK, Del., May 5, 2014 (GLOBE NEWSWIRE) -- Navient, the nation's leading loan management, servicing and asset recovery company, announced that William M.
Sign-up for Navient announces William M. Diefenderfer III as chairman, names directors investment picks
2014/5/1
NEWARK, Del., May 1, 2014 (GLOBE NEWSWIRE) -- Navient, the nation's leading loan management, servicing and asset recovery company, today marks its launch as an independent company dedicated to helping customers navigate the path to financial success.
Sign-up for Navient Celebrates Launch as New Leader in Loan Servicing and Asset Recovery, Dedicated to Helping Customers Navigate the Path to Financial Success investment picks
2014/5/19
NEWARK, Del., May 19, 2014 (GLOBE NEWSWIRE) -- Navient, the nation's leading loan management, servicing and asset recovery company, announced that Linda A.
Sign-up for Navient names Northrop Grumman executive Linda A. Mills to board of directors investment picks
NEW YORK, NY, May 1, 2014 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) announced today that its principal underwriting agency subsidiary, Navigators Management Company, Inc., has appointed Linda K.
Sign-up for Navigators Appoints New Life Sciences Senior Vice President investment picks
STAMFORD, Conn., May 7, 2014 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (Nasdaq:NAVG) reported net income of $28.0 million, or $1.94 per diluted share, for the three months ended March 31, 2014 compared to $13.9 million, or $0.97 per diluted share, for the comparable period in 2013.
Sign-up for Navigators Reports First Quarter Earnings, Operating Earnings Up 94% investment picks
NEW YORK, NY, May 5, 2014 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) today announced that Stanley A.
Sign-up for Navigators to Present at William Blair Growth Stock Conference investment picks
http://media.marketwire.com/attachments/201102/19919_MaritimeAcquisitionCorpLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1115498&ProfileId=051205&sourceType=1 MONACO --
Sign-up for Navios Maritime Acquisition Corporation Reports Financial Results for the First Quarter Ended March 31, 2014 investment picks
2014/5/14
http://media.marketwire.com/attachments/201101/19589_navios.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1115691&ProfileId=051205&sourceType=1 MONACO --
Sign-up for Navios Maritime Holdings Inc. Announces the Date for the Release of First Quarter 2014 Results, Conference Call and Webcast investment picks
2014/5/21
http://media.marketwire.com/attachments/201101/19589_navios.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1117270&ProfileId=051205&sourceType=1 MONACO --
Sign-up for Navios Maritime Holdings Inc. Reports Financial Results for the First Quarter Ended March 31, 2014 investment picks
NORWICH, N.Y., April 28, 2014 (GLOBE NEWSWIRE) -- NBT Bancorp Inc. (NBT) (Nasdaq:NBTB) reported net income for the three months ended March 31, 2014 was $18.0 million, up from $7.6 million for the same period last year.
Sign-up for NBT Bancorp Inc. Announces Net Income of $18.0 Million and Organic Loan Growth of 5.6% for the First Quarter of 2014 investment picks
HOUSTON , May 12, 2014 /PRNewswire/ -- NCI Building Systems, Inc. (NYSE: NCS) announced today that it will release financial results for its fiscal year 2014 second quarter ended May 4, 2014 , after the market closes on Tuesday, June 10 , 2014.
Sign-up for NCI Building Systems Announces Fiscal Year 2014 Second Quarter Earnings Release and Conference Call Schedule investment picks
NCR Corporation (NYSE: NCR) announced today that it will participate at the Bank of America Merrill Lynch Services One-on-One Conference 2014 on Tuesday, May 20 at the Bank of America Tower at One Bryant Park in New York.
Sign-up for NCR to Present at the Bank of America Merrill Lynch Services One-on-One Conference 2014 investment picks
NCR Corporation (NYSE: NCR) announced today that it will participate at the KeyBanc Capital Markets Industrial, Automotive & Transportation Conference on Wednesday, May 28 at the InterContinental Boston.
Sign-up for NCR to Present at the KeyBanc Capital Markets® Industrial, Automotive & Transportation Conference investment picks
Financial Security Declines as More Americans Worry about Job Security NEW YORK , May 12, 2014 /PRNewswire/ -- Nearly eight in 10 Americans (78%) carry less than $50 in cash on a daily basis, according to a new Bankrate.com (NYSE: RATE) report.
Sign-up for Nearly Eight in 10 Americans Carry Less Than $50 in Cash investment picks
2010/02/20
Tips, strategies, and picks for tax-conscious investors: Feb. 15-19.
Sign-up for Need Tax Relief? We Have Your Prescription investment picks
SAN FRANCISCO , May 16, 2014 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) is scheduled to present at the upcoming UBS 2014 Global Healthcare Conference in New York at the Sheraton New York Hotel on Tuesday, May 20, 2014 at 2:30 p.m. Eastern time .
Sign-up for Nektar Therapeutics To Present at the UBS 2014 Global Healthcare Conference in New York City investment picks
SANTA CLARA, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- Neonode Inc. (Nasdaq:NEON) , the optical touch technology company, announced today the closing of a previously-announced private placement of common stock for $10 million in gross proceeds.
Sign-up for Neonode Announces Closing of $10 Million Private Placement investment picks
SANTA CLARA, Calif., May 9, 2014 (GLOBE NEWSWIRE) -- Neonode Inc. (Nasdaq:NEON) , the optical touch technology company, announced today that it has entered into a definitive purchase agreement with an institutional investor in a private placement of common stock for $10 million in gross proceeds.
Sign-up for Neonode Raises $10 Million in a Private Placement investment picks
SANTA CLARA, Calif., May 6, 2014 (GLOBE NEWSWIRE) -- Neonode Inc ., (Nasdaq:NEON) , the optical touch technology company, announced today that it will release financial results for the three months ended March 31, 2014 on Monday, May 12, 2014.
Sign-up for Neonode(R) to Report First Quarter 2014 Results on May 12, 2014 investment picks
NEW YORK, May 21, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that Dr.
Sign-up for NeoStem Announces CEO Dr. Robin L. Smith Selected as Finalist for EY Entrepreneur of the Year 2014 Award investment picks
NEW YORK, May 13, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company has signed an exclusive license agreement with China-based Cellular Biomedicine Group (OTCQB:CBMG) ("CBMG") to begin a Phase 2 clinical trial in patients with late stage liver cancer.
Sign-up for NeoStem Announces Licensing Agreement and Plans to Begin Phase 2 Hepatocellular Carcinoma Trial in China investment picks
NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) and its subsidiary, Progenitor Cell Therapy, LLC ("PCT"), announced the execution of a Services Agreement with IRX Therapeutics, Inc. ("IRX") under which PCT will provide services to support IRX's development of IRX-2, a primary cell-derived biologic with multiple active cytokine components.
Sign-up for NeoStem's Subsidiary, Progenitor Cell Therapy Enters Into a Services Agreement With IRX Therapeutics, Inc. investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: National Research Corporation to Broadcast Its 2014 First Quarter Conference Call Live on the Internet to NeoStem's Subsidiary, Progenitor Cell Therapy Enters Into a Services Agreement With IRX Therapeutics, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry